Flagship Pioneering, LLC - 12 Feb 2024 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Reporting relationship: 10%+ Owner
Issuer ticker: SANA
Reported as of: 12 Feb 2024
Net transaction value: +$14,999,723
SEC form: 4
Accepted by SEC: 14 Feb 2024, 16:00:13 UTC
Prior SEC filing: 15 Sep 2023
Next SEC filing: 24 May 2024
Source filing: View source filing
Reporting owner signature: Flagship Pioneering, Inc., By: /s/ Noubar B. Afeyan, Ph.D., Title: CEP

Key filing fact

Flagship Pioneering, LLC filed Form 4 for Sana Biotechnology, Inc. (SANA) on 14 Feb 2024.

Key facts

This page summarizes Flagship Pioneering, LLC's Form 4 filing for Sana Biotechnology, Inc. (SANA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Feb 2024, 16:00.

Change

Previous filing in this sequence was filed on 15 Sep 2023.
Current net transaction value: +$14,999,723.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SANA transaction Derivative

Pre-Funded Warrants to purchase Common Stock

Purchase

Transaction value: $14,999,723
Shares: +2,727,272
Change %
Price: $5.50
Shares after: 2,727,272
Date: 12 Feb 2024
Ownership: By Flagship Pioneering Fund VII, L.P.
Underlying class: Common Stock
Underlying amount: 2,727,272
Exercise price: $0.000100
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On February 12, 2024, pursuant to an underwritten public offering by the Issuer, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired pre-funded warrants to purchase 2,727,272 shares of Common Stock (the "Pre-Funded Warrants") at a purchase price of $5.4999 per Pre-Funded Warrant. The Pre-Funded Warrants do not have an expiration date.

Footnote F2

Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.